Snapshot from Jul 07, 2026 at 01:18 UTC. For live data and tracking: View Live
Entities / Companies / Datar Cancer Genetics
Entity

Datar Cancer Genetics

Tracked across 1 events · 7 articles · First seen May 14, 2026 · Last active May 14, 2026

Sentiment
80
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 80
Regulatory
Datar Cancer Genetics US FDA Clearance
Impact: Datar Cancer Genetics received US FDA clearance for its CellDx-Tissue assay, strengthening its position in precision oncology and enabling broader market engagement.
May 14, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Datar Cancer Genetics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.